Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.The Jiading District Government of Shanghai organized statistics on the arrears of dealers. The reporter was informed that the relevant departments of the Jiading District Government of Shanghai have stepped in to count the arrears of dealers. At about 13: 00 on December 13th, the reporter of Beijing News Shell Finance saw at the registration site of Shanghai Yongqiao Village Committee that a staff member was organizing the dealers present to fill out the form, and the information collected included the name of the company, contact person, goods supplied, amount owed, due date, etc. (Shell Finance)The CSRC approved the registration application of Jiangnan New Materials Technology Co., Ltd. for initial public offering of shares.
Barclays: Raise the target price of Standard Chartered from 940p to 970p.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.According to the latest announcement of Allianz Fund, due to work arrangement, Shen Liang stepped down as general manager and financial controller on December 12, and Duan Jing became the new financial controller, and there is no statement about his transfer to other positions in the company. As early as October 8th, the former Inspector General Gu Wen left his post for personal reasons, and Shen Liang acted as Inspector General. Allianz Fund is the ninth wholly foreign-owned public offering in China, which is wholly owned by Allianz Investment. On April 18th this year, it was approved to launch China Public Offering of Fund business, and the first public offering product was established in early September. Before leaving office, Shen Liang served as director, general manager, legal representative and financial controller of Allianz Fund. According to the data, Shen Liang, Gu Wen and Duan Jing joined Allianz Investment in January 2021, August 2021 and May 2022 respectively.
Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Guangdong: In the next five years, 10 billion yuan will be invested to support the development of the tourism industry. On December 12th, a site meeting was held to promote the implementation of the spirit of the provincial tourism development conference in Guangdong. The meeting proposed to promote the implementation of the "three hundred" plan for cultural tourism investment, that is, to promote 100 major projects under construction and 100 key investment projects, to coordinate provincial financial investment of 10 billion yuan to support the development of tourism industry in the next five years, and to accelerate the implementation of the list of 100 major projects under construction and 100 key investment projects. According to the deployment, Guangdong will focus on promoting the implementation of the "three hundred" plan for cultural tourism investment and establishing "three lists" for key cultural tourism projects (namely, the list of projects under construction, the list of investment projects and the list of projects supported by financial funds). According to statistics, there are 103 major cultural tourism projects under construction in Guangdong province, with a total investment of 282.6 billion yuan, and the accumulated investment has reached 74 billion yuan by the third quarter.The retail price of refined oil may end up stranded. According to calculation, as of the seventh working day on December 13th, the average price of reference crude oil varieties was 70.58 USD/barrel, with a change rate of -0.87%, and the corresponding domestic retail price of gasoline and diesel should be lowered by 40 yuan/ton. At 24: 00 on December 18th, it is the last price adjustment window of the retail price in 2024, so the retail price is likely to end stranded. By December 13th, 2024, the domestic retail price of gasoline and diesel had experienced "9 up, 9 down and 6 stranded". After the fluctuation offset, gasoline and diesel (standard products) were reduced by 115 yuan/ton and 125 yuan/ton respectively. (Jin Lianchuang)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14